{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:44:05Z","timestamp":1788407045028,"version":"build-2803163510"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s13318-023-00823-x","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T17:02:06Z","timestamp":1680714126000},"page":"281-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Analysis of Pethidine Pharmacokinetics in Newborn Saliva, Plasma, and Brain Extracellular Fluid After Prenatal Intrauterine Exposure from Pregnant Mothers Receiving Intramuscular Dose Using PBPK Modeling"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0640-8085","authenticated-orcid":false,"given":"Mo\u2019tasem M.","family":"Alsmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Idkaidek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"823_CR1","volume-title":"Pain and analgesics","author":"MC Lee","year":"2012","unstructured":"Lee MC, Abrahams M. Pain and analgesics. 11th ed. London: Elsevier; 2012.","edition":"11"},{"key":"823_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1515\/jpme.1986.14.1.3","volume":"14","author":"R Huch","year":"1986","unstructured":"Huch R. Maternal hyperventilation and the fetus. J Perinat Med. 1986;14:3\u201317. https:\/\/doi.org\/10.1515\/jpme.1986.14.1.3.","journal-title":"J Perinat Med"},{"key":"823_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S0140-6736(66)90639-8","volume":"287","author":"E Motoyama","year":"1966","unstructured":"Motoyama E, Acheson F, Rivard G, Cook C. Adverse effect of maternal hyperventilation on the fetus. Lancet. 1966;287:286\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(66)90639-8.","journal-title":"Lancet"},{"key":"823_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/00016347409156885","volume":"53","author":"B Thalme","year":"1974","unstructured":"Thalme B, Belfrage P, Raabe N. Lumbar epidural analgesia in labour. Acta Obstet Gynecol Scand. 1974;53:27\u201335. https:\/\/doi.org\/10.3109\/00016347409156885.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"823_CR5","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1213\/ane.0b013e3181617451","volume":"106","author":"S Segal","year":"2008","unstructured":"Segal S, Wang SY. The effect of maternal catecholamines on the caliber of gravid uterine microvessels. Anesth Analg. 2008;106:888\u201392. https:\/\/doi.org\/10.1213\/ane.0b013e3181617451.","journal-title":"Anesth Analg"},{"key":"823_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.bpobgyn.2009.11.003","volume":"24","author":"F Reynolds","year":"2010","unstructured":"Reynolds F. The effects of maternal labour analgesia on the fetus. Best Pract Res Clin Obstet Gynaecol. 2010;24:289\u2013302. https:\/\/doi.org\/10.1016\/j.bpobgyn.2009.11.003.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"823_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0033-1351138","volume":"26","author":"V Garimella","year":"2013","unstructured":"Garimella V, Cellini C. Postoperative pain control. Clin Colon Rectal Surg. 2013;26:191\u20136. https:\/\/doi.org\/10.1055\/s-0033-1351138.","journal-title":"Clin Colon Rectal Surg"},{"key":"823_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/0310057X9802600202","volume":"26","author":"WN Kee","year":"1998","unstructured":"Kee WN. Intrathecal pethidine: pharmacology and clinical applications. Anaesth Intensive Care. 1998;26:137\u201346. https:\/\/doi.org\/10.1177\/0310057X9802600202.","journal-title":"Anaesth Intensive Care"},{"key":"823_CR9","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/adc.52.8.638","volume":"52","author":"LV Cooper","year":"1977","unstructured":"Cooper LV, Stephen GW, Aggett PJ. Elimination of pethidine and bupivacaine in the newborn. Arch Dis Child. 1977;52:638\u201341. https:\/\/doi.org\/10.1136\/adc.52.8.638.","journal-title":"Arch Dis Child"},{"key":"823_CR10","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/j.1471-0528.1980.tb04459.x","volume":"87","author":"SF Freeborn","year":"1980","unstructured":"Freeborn SF, Calvert RT, Black P, Macfarlane T, D\u2019Souza SW. Saliva and blood pethidine concentrations in the mother and the newborn baby. BJOG. 1980;87:966\u20139. https:\/\/doi.org\/10.1111\/j.1471-0528.1980.tb04459.x.","journal-title":"BJOG"},{"key":"823_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3109\/00016348109154108","volume":"60","author":"P Belfrage","year":"1981","unstructured":"Belfrage P, Bor\u00e9us LO, Hartvig P, Irestedt L, Raabe N. Neonatal depression after obstetrical analgesia with pethidine. The role of the injection-delivery time interval and of the plasma concentrations of pethidine and norpethidine. Acta Obstet Gynecol Scand. 1981;60:43\u20139. https:\/\/doi.org\/10.3109\/00016348109154108.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"823_CR12","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/bph.14105","volume":"175","author":"A Rickli","year":"2018","unstructured":"Rickli A, Liakoni E, Hoener MC, Liechti ME. Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome. Br J Pharmacol. 2018;175:532\u201343. https:\/\/doi.org\/10.1111\/bph.14105.","journal-title":"Br J Pharmacol"},{"key":"823_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/mds.870090126","volume":"9","author":"J Olive","year":"1994","unstructured":"Olive J, Masana L, Gonzalez J. Meperidine and reversible parkinsonism. Mov Disord. 1994;9:115\u20136. https:\/\/doi.org\/10.1002\/mds.870090126.","journal-title":"Mov Disord"},{"key":"823_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/0028-3908(84)90107-2","volume":"23","author":"FC Tortella","year":"1984","unstructured":"Tortella FC, Cowan A, Adler MW. Studies on the excitatory and inhibitory influence of intracerebroventricularly injected opioids on seizure thresholds in rats. Neuropharmacology. 1984;23:749\u201354. https:\/\/doi.org\/10.1016\/0028-3908(84)90107-2.","journal-title":"Neuropharmacology"},{"key":"823_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00045391-200201000-00010","volume":"9","author":"KS Latta","year":"2002","unstructured":"Latta KS, Ginsberg B, Barkin RL. Meperidine: a critical review. Am J Ther. 2002;9:53\u201368.","journal-title":"Am J Ther"},{"key":"823_CR16","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1592\/phco.24.8.776.36066","volume":"24","author":"CF Seifert","year":"2004","unstructured":"Seifert CF, Kennedy S. Meperidine is alive and well in the new millennium: evaluation of meperidine usage patterns and frequency of adverse drug reactions. Pharmacotherapy. 2004;24:776\u201383. https:\/\/doi.org\/10.1592\/phco.24.8.776.36066.","journal-title":"Pharmacotherapy"},{"key":"823_CR17","unstructured":"World Health Organization. WHO recommendation on opioid analgesia for pain relief during labour. 2021. https:\/\/srhr.org\/rhl\/article\/who-recommendation-on-opioid-analgesia-for-pain-relief-during-labour. Accessed 24 Feb 2023."},{"key":"823_CR18","doi-asserted-by":"publisher","first-page":"972","DOI":"10.2174\/1389200219666180702104034","volume":"19","author":"MM Alsmadi","year":"2018","unstructured":"Alsmadi MM, Idkaidek N. Optimization of drugs pharmacotherapy during pregnancy using physiologically based pharmacokinetic models-an update. Curr Drug Metab. 2018;19:972\u20138. https:\/\/doi.org\/10.2174\/1389200219666180702104034.","journal-title":"Curr Drug Metab"},{"key":"823_CR19","unstructured":"Food U, Administration D. Guidance for industry. Pharmacokinetics in pregnancy\u2014study design, data analysis, and impact on dosing and labeling. 2004. 2017. Accessed 21 Feb 2023."},{"key":"823_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/bcp.13438","volume":"84","author":"SM Illamola","year":"2018","unstructured":"Illamola SM, Bucci-Rechtweg C, Costantine MM, Tsilou E, Sherwin CM, Zajicek A. Inclusion of pregnant and breastfeeding women in research\u2013efforts and initiatives. Br J Clin Pharmacol. 2018;84:215\u201322. https:\/\/doi.org\/10.1111\/bcp.13438.","journal-title":"Br J Clin Pharmacol"},{"key":"823_CR21","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology\u2014drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157\u201367. https:\/\/doi.org\/10.1056\/NEJMra035092.","journal-title":"N Engl J Med"},{"key":"823_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s40262-019-00836-3","volume":"59","author":"K Abduljalil","year":"2020","unstructured":"Abduljalil K, Jamei M, Johnson TN. Fetal physiologically based pharmacokinetic models: systems information on fetal blood components and binding proteins. Clin Pharmacokinet. 2020;59:629\u201342. https:\/\/doi.org\/10.1007\/s40262-019-00836-3.","journal-title":"Clin Pharmacokinet"},{"key":"823_CR23","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1056\/NEJM200010123431515","volume":"343","author":"GW Jong","year":"2000","unstructured":"Jong GW, Vulto AG, de Hoog M, Schimmel KJ, Tibboel D, van den Anker JN. Unapproved and off-label use of drugs in a children\u2019s hospital. N Engl J Med. 2000;343:1125. https:\/\/doi.org\/10.1056\/NEJM200010123431515.","journal-title":"N Engl J Med"},{"key":"823_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/bmj.320.7227.79","volume":"320","author":"S Conroy","year":"2000","unstructured":"Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. Br Med J. 2000;320:79\u201382. https:\/\/doi.org\/10.1136\/bmj.320.7227.79.","journal-title":"Br Med J"},{"key":"823_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-3-642-20195-0_3","volume-title":"Pediatric clinical pharmacology","author":"W Zhao","year":"2011","unstructured":"Zhao W, Jacqz-Aigrain E. Principles of therapeutic drug monitoring. In: Seyberth HW, Rane A, Schwab M, editors. Pediatric clinical pharmacology. Berlin: Springer; 2011. p. 77\u201390."},{"key":"823_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF00561475","volume":"18","author":"PL Morselli","year":"1980","unstructured":"Morselli PL, Rovei V. Placental transfer of pethidine and norpethidine and their pharmacokinetics in the newborn. Eur J Clin Pharmacol. 1980;18:25\u201330. https:\/\/doi.org\/10.1007\/BF00561475.","journal-title":"Eur J Clin Pharmacol"},{"key":"823_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000315578","volume-title":"Guide to paediatric drug development and clinical research","author":"D Hawcutt","year":"2010","unstructured":"Hawcutt D, Rose A, Fuerst-Recktenwald SNT, Turner M. Points to consider when planning the collection of blood or tissue samples in clinical trials of investigational medicinal products in children, infants and neonates. In: Van den Anker J, Rose K, editors. Guide to paediatric drug development and clinical research. Washington D.C: Karger Publishers; 2010. p. 97\u2013110."},{"key":"823_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000457481","volume":"19","author":"R Gorodischer","year":"1992","unstructured":"Gorodischer R, Koren G. Salivary excretion of drugs in children: theoretical and practical issues in therapeutic drug monitoring. Dev Pharmacol Ther. 1992;19:161\u201377. https:\/\/doi.org\/10.1159\/000457481.","journal-title":"Dev Pharmacol Ther"},{"key":"823_CR29","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/cpt1975186742","volume":"18","author":"CE Cook","year":"1975","unstructured":"Cook CE, Amerson E, Poole WK, Lesser P, O\u2019Tuama L. Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay. Clin Pharmacol Ther. 1975;18:742\u20137. https:\/\/doi.org\/10.1002\/cpt1975186742.","journal-title":"Clin Pharmacol Ther"},{"key":"823_CR30","first-page":"238","volume":"86","author":"A Tal","year":"1990","unstructured":"Tal A, Aviram M, Gorodischer R. Variations in theophylline concentrations detected by 24-hour saliva concentration profiles in ambulatory children with asthma. J Allergy Clin Immunol. 1990;86:238\u201343.","journal-title":"J Allergy Clin Immunol"},{"key":"823_CR31","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/00007691-200010000-00003","volume":"22","author":"I Tsiropoulos","year":"2000","unstructured":"Tsiropoulos I, Kristensen O, Klitgaard NA. Saliva and serum concentration of lamotrigine in patients with epilepsy. Ther Drug Monit. 2000;22:517\u201321. https:\/\/doi.org\/10.1097\/00007691-200010000-00003.","journal-title":"Ther Drug Monit"},{"key":"823_CR32","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s002280000179","volume":"56","author":"T Gordi","year":"2000","unstructured":"Gordi T, Hai TN, Hoai NM, Thyberg M, Ashton M. Use of saliva and capillary blood samples as substitutes for venous blood sampling in pharmacokinetic investigations of artemisinin. Eur J Clin Pharmacol. 2000;56:561\u20136. https:\/\/doi.org\/10.1007\/s002280000179.","journal-title":"Eur J Clin Pharmacol"},{"key":"823_CR33","doi-asserted-by":"publisher","first-page":"250","DOI":"10.21203\/rs.3.rs-236907\/v1","volume":"23","author":"A Garc\u00eda-Robles","year":"2021","unstructured":"Garc\u00eda-Robles A, Solaz-Garc\u00eda \u00c1, Verd\u00fa-Andr\u00e9s J, Poveda-Andr\u00e9s JL, Ch\u00e1fer-Peric\u00e1s C, Ponce-Rodriguez HD, et al. The usefulness of saliva in therapeutic drug monitoring of caffeine in preterm infants. Ther Drug Monit. 2021;23:250\u20134. https:\/\/doi.org\/10.21203\/rs.3.rs-236907\/v1.","journal-title":"Ther Drug Monit"},{"key":"823_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1055\/a-1233-3582","volume":"70","author":"N Idkaidek","year":"2020","unstructured":"Idkaidek N, Hamadi S, Bani-Domi R, Al-Adham I, Alsmadi M, Awaysheh F, et al. Saliva versus Plasma Therapeutic Drug Monitoring of Gentamicin in Jordanian Preterm Infants. Development of a Physiologically-Based Pharmacokinetic (PBPK) Model and Validation of Class II Drugs of Salivary Excretion Classification System. Drug Res. 2020;70:455\u201362. https:\/\/doi.org\/10.1055\/a-1233-3582.","journal-title":"Drug Res"},{"key":"823_CR35","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/bcp.13553","volume":"84","author":"L Hutchinson","year":"2018","unstructured":"Hutchinson L, Sinclair M, Reid B, Burnett K, Callan B. A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants. Br J Clin Pharmacol. 2018;84:1089\u2013108. https:\/\/doi.org\/10.1111\/bcp.13553.","journal-title":"Br J Clin Pharmacol"},{"key":"823_CR36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2165\/00003088-199223050-00003","volume":"23","author":"RK Drobitch","year":"1992","unstructured":"Drobitch RK, Svensson CK. Therapeutic drug monitoring in saliva. Clin Pharmacokinet. 1992;23:365\u201379. https:\/\/doi.org\/10.2165\/00003088-199223050-00003.","journal-title":"Clin Pharmacokinet"},{"key":"823_CR37","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1021\/mp300250r","volume":"9","author":"N Idkaidek","year":"2012","unstructured":"Idkaidek N, Arafat T. Saliva versus plasma pharmacokinetics: theory and application of a salivary excretion classification system. Mol Pharm. 2012;9:2358\u201363. https:\/\/doi.org\/10.1021\/mp300250r.","journal-title":"Mol Pharm"},{"key":"823_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jsps.2013.02.002","volume":"22","author":"NM Idkaidek","year":"2014","unstructured":"Idkaidek NM. Interplay of biopharmaceutics, biopharmaceutics drug disposition and salivary excretion classification systems. Saudi Pharm J. 2014;22:79\u201381. https:\/\/doi.org\/10.1016\/j.jsps.2013.02.002.","journal-title":"Saudi Pharm J."},{"key":"823_CR39","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/bcp.13001","volume":"82","author":"NR Dobson","year":"2016","unstructured":"Dobson NR, Liu X, Rhein LM, Darnall RA, Corwin MJ, McEntire BL, et al. Salivary caffeine concentrations are comparable to plasma concentrations in preterm infants receiving extended caffeine therapy. Br J Clin Pharmacol. 2016;82:754\u201361. https:\/\/doi.org\/10.1111\/bcp.13001.","journal-title":"Br J Clin Pharmacol"},{"key":"823_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00006199-199503000-00010","volume":"44","author":"H-P Chang","year":"1995","unstructured":"Chang H-P, Anderson GC, Wood CE. Feasible and valid saliva collection for cortisol in transitional newborn infants. Nurs Res. 1995;44:117\u20139.","journal-title":"Nurs Res"},{"key":"823_CR41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/BF01059198","volume":"14","author":"JL Gabrielsson","year":"1986","unstructured":"Gabrielsson JL, Johansson P, Bondesson U, Karlsson M, Paalzow LK. Analysis of pethidine disposition in the pregnant rat by means of a physiological flow model. J Pharmacokinet Biopharm. 1986;14:381\u201395. https:\/\/doi.org\/10.1007\/BF01059198.","journal-title":"J Pharmacokinet Biopharm"},{"key":"823_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/ana.410130213","volume":"13","author":"RF Kaiko","year":"1983","unstructured":"Kaiko RF, Foley KM, Grabinski PY, Heidrich G, Rogers AG, Inturrisi CE, et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol. 1983;13:180\u20135. https:\/\/doi.org\/10.1002\/ana.410130213.","journal-title":"Ann Neurol"},{"key":"823_CR43","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2165\/00003088-197803050-00002","volume":"3","author":"LE Mather","year":"1978","unstructured":"Mather LE, Meffin PJ. Clinical pharmacokinetics pethidine. Clin Pharmacokinet. 1978;3:352\u201368. https:\/\/doi.org\/10.2165\/00003088-197803050-00002.","journal-title":"Clin Pharmacokinet"},{"key":"823_CR44","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/clpt.1992.153","volume":"52","author":"M-L Pokela","year":"1992","unstructured":"Pokela M-L, Olkkola KT, Koivisto M, Ryh\u00e4nen P. Pharmacokinetics and pharmacodynamics of intravenous meperidine in neonates and infants. Clin Pharmacol Ther. 1992;52:342\u20139. https:\/\/doi.org\/10.1038\/clpt.1992.153.","journal-title":"Clin Pharmacol Ther"},{"key":"823_CR45","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1365-2125.1984.tb02563.x","volume":"18","author":"D Guay","year":"1984","unstructured":"Guay D, Meatherall R, Chalmers J, Grahame G. Cimetidine alters pethidine disposition in man. Br J Clin Pharmacol. 1984;18:907\u201314. https:\/\/doi.org\/10.1111\/j.1365-2125.1984.tb02563.x.","journal-title":"Br J Clin Pharmacol"},{"key":"823_CR46","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/0002-9378(89)90185-3","volume":"160","author":"N Lazebnik","year":"1989","unstructured":"Lazebnik N, Kuhnert BR, Carr PC, Brashear WT, Syracuse CD, Mann LI. Intravenous, deltoid, or gluteus administration of meperidine during labor? Am J Obstet Gynecol. 1989;160:1184\u20139. https:\/\/doi.org\/10.1016\/0002-9378(89)90185-3.","journal-title":"Am J Obstet Gynecol"},{"key":"823_CR47","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1002\/jcph.1483","volume":"59","author":"K Allegaert","year":"2019","unstructured":"Allegaert K, van den Anker J. Ontogeny of phase I metabolism of drugs. J Clin Pharmacol. 2019;59:S33\u201341. https:\/\/doi.org\/10.1002\/jcph.1483.","journal-title":"J Clin Pharmacol"},{"key":"823_CR48","unstructured":"Bayer Technology Services GmbH. Open Systems Pharmacology Suite. 2019. https:\/\/docs.open-systems-pharmacology.org\/working-with-pk-sim\/pk-sim-documentation. Accessed 10 Jun 2021."},{"key":"823_CR49","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s40262-017-0594-5","volume":"57","author":"A Dallmann","year":"2018","unstructured":"Dallmann A, Ince I, Coboeken K, Eissing T, Hempel G. A physiologically based pharmacokinetic model for pregnant women to predict the pharmacokinetics of drugs metabolized via several enzymatic pathways. Clin Pharmacokinet. 2018;57:749\u201368. https:\/\/doi.org\/10.1007\/s40262-017-0594-5.","journal-title":"Clin Pharmacokinet"},{"key":"823_CR50","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/clpt.1981.65","volume":"29","author":"RL Nation","year":"1981","unstructured":"Nation RL. Meperidine binding in maternal and fetal plasma. Clin Pharmacol Ther. 1981;29:472\u20139. https:\/\/doi.org\/10.1038\/clpt.1981.65.","journal-title":"Clin Pharmacol Ther"},{"key":"823_CR51","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/j.1552-4604.1987.tb03059.x","volume":"27","author":"K Chan","year":"1987","unstructured":"Chan K, Tse J, Jennings F, Orme MLE. Pharmacokinetics of low-dose intravenous pethidine in patients with renal dysfunction. J Clin Pharmacol. 1987;27:516\u201322. https:\/\/doi.org\/10.1002\/j.1552-4604.1987.tb03059.x.","journal-title":"J Clin Pharmacol"},{"key":"823_CR52","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.1002\/jps.22726","volume":"100","author":"K Thelen","year":"2011","unstructured":"Thelen K, Coboeken K, Willmann S, Burghaus R, Dressman JB, Lippert J. Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1: oral solutions. J Pharm Sci. 2011;100:5324\u201345. https:\/\/doi.org\/10.1002\/jps.22726.","journal-title":"J Pharm Sci"},{"key":"823_CR53","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1691\/ph.2018.8014","volume":"73","author":"J Cao","year":"2018","unstructured":"Cao J, Du Y, Wang YJ, Wu B, Jia J, Wei ZW, et al. Pharmacokinetics of meperidine (pethidine) in rabbit oral fluid: correlation with plasma concentrations after controlled administration. Pharmazie. 2018;73:324\u20138. https:\/\/doi.org\/10.1691\/ph.2018.8014.","journal-title":"Pharmazie"},{"key":"823_CR54","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1023\/A:1026194618660","volume":"30","author":"S Bj\u00f6rkman","year":"2003","unstructured":"Bj\u00f6rkman S. Reduction and lumping of physiologically based pharmacokinetic models: prediction of the disposition of fentanyl and pethidine in humans by successively simplified models. J Pharmacokinet Pharmacodyn. 2003;30:285\u2013307. https:\/\/doi.org\/10.1023\/A:1026194618660.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"823_CR55","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/bja\/70.3.248","volume":"70","author":"NR Davis","year":"1993","unstructured":"Davis NR, Mapleson WW. A physiological model for the distribution of injected agents, with special reference to pethidine. Br J Anaesth. 1993;70:248\u201358. https:\/\/doi.org\/10.1093\/bja\/70.3.248.","journal-title":"Br J Anaesth"},{"key":"823_CR56","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1365-2125.1982.tb01432.x","volume":"13","author":"G Tomson","year":"1982","unstructured":"Tomson G, Garle R, Thalme B, Nisell H, Nylund L, Rane A. Maternal kinetics and transplacental passage of pethidine during labour. Br J Clin Pharmacol. 1982;13:653\u20139. https:\/\/doi.org\/10.1111\/j.1365-2125.1982.tb01432.x.","journal-title":"Br J Clin Pharmacol"},{"key":"823_CR57","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1517\/17425255.3.2.235","volume":"3","author":"I Nestorov","year":"2007","unstructured":"Nestorov I. Whole-body physiologically based pharmacokinetic models. Expert Opin Drug Metab Toxicol. 2007;3:235\u201349. https:\/\/doi.org\/10.1517\/17425255.3.2.235.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"823_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00827-4","author":"K Abduljalil","year":"2019","unstructured":"Abduljalil K, Pan X, Pansari A, Jamei M, Johnson TN. Preterm physiologically based pharmacokinetic model. Part II: applications of the model to predict drug pharmacokinetics in the preterm population. Clin Pharmacokinet. 2019. https:\/\/doi.org\/10.1007\/s40262-019-00827-4.","journal-title":"Clin Pharmacokinet"},{"key":"823_CR59","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40262-019-00825-6","volume":"59","author":"K Abduljalil","year":"2020","unstructured":"Abduljalil K, Pan X, Pansari A, Jamei M, Johnson TN. A preterm physiologically based pharmacokinetic model. Part I: physiological parameters and model building. Clin Pharmacokinet. 2020;59:485\u2013500. https:\/\/doi.org\/10.1007\/s40262-019-00825-6.","journal-title":"Clin Pharmacokinet"},{"key":"823_CR60","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.2174\/1381612821666150901110533","volume":"21","author":"K Claassen","year":"2015","unstructured":"Claassen K, Thelen K, Coboeken K, Gaub T, Lippert J, Allegaert K, et al. Development of a physiologically-based pharmacokinetic model for preterm neonates: evaluation with in vivo data. Curr Pharm Des. 2015;21:5688\u201398. https:\/\/doi.org\/10.2174\/1381612821666150901110533.","journal-title":"Curr Pharm Des"},{"key":"823_CR61","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/psp4.12300","volume":"7","author":"A Dallmann","year":"2018","unstructured":"Dallmann A, Solodenko J, Ince I, Eissing T. Applied concepts in PBPK modeling: how to extend an open systems pharmacology model to the special population of pregnant women. CPT Pharmacometrics Syst Pharmacol. 2018;7:419\u201331. https:\/\/doi.org\/10.1002\/psp4.12300.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"823_CR62","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s40262-017-0539-z","volume":"56","author":"A Dallmann","year":"2017","unstructured":"Dallmann A, Ince I, Meyer M, Willmann S, Eissing T, Hempel G. Gestation-specific changes in the anatomy and physiology of healthy pregnant women: an extended repository of model parameters for physiologically based pharmacokinetic modeling in pregnancy. Clin Pharmacokinet. 2017;56:1303\u201330. https:\/\/doi.org\/10.1007\/s40262-017-0539-z.","journal-title":"Clin Pharmacokinet"},{"key":"823_CR63","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s40262-020-00977-w","volume":"60","author":"XI Liu","year":"2021","unstructured":"Liu XI, Momper JD, Rakhmanina NY, Green DJ, Burckart GJ, Cressey TR, et al. Physiologically based pharmacokinetic modeling framework to predict neonatal pharmacokinetics of transplacentally acquired emtricitabine, dolutegravir, and raltegravir. Clin Pharmacokinet. 2021;60:795\u2013809. https:\/\/doi.org\/10.1007\/s40262-020-00977-w.","journal-title":"Clin Pharmacokinet"},{"key":"823_CR64","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10928-007-9053-5","volume":"34","author":"S Willmann","year":"2007","unstructured":"Willmann S, H\u00f6hn K, Edginton A, Sevestre M, Solodenko J, Weiss W, et al. Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs. J Pharmacokinet Pharmacodyn. 2007;34:401\u201331. https:\/\/doi.org\/10.1007\/s10928-007-9053-5.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"823_CR65","doi-asserted-by":"publisher","first-page":"738","DOI":"10.7326\/0003-4819-86-6-738","volume":"86","author":"HH Szeto","year":"1977","unstructured":"Szeto HH, Inturrisi CE, Houde R, Saal S, Cheigh J, Reidenberg MM. Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure or cancer. Ann Intern Med. 1977;86:738\u201341. https:\/\/doi.org\/10.7326\/0003-4819-86-6-738.","journal-title":"Ann Intern Med"},{"key":"823_CR66","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1093\/bja\/71.5.738","volume":"71","author":"P Stone","year":"1993","unstructured":"Stone P, Macintyre P, Jarvis D. Norpethidine toxicity and patient controlled analgesia. BJA Br J Anaesthesia. 1993;71:738\u201340. https:\/\/doi.org\/10.1093\/bja\/71.5.738.","journal-title":"BJA Br J Anaesthesia."},{"key":"823_CR67","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/106002809302700106","volume":"27","author":"KO Hagmeyer","year":"1993","unstructured":"Hagmeyer KO, Mauro LS, Mauro VF. Meperidine-related seizures associated with patient-controlled analgesia pumps. Ann Pharmacother. 1993;27:29\u201332. https:\/\/doi.org\/10.1177\/106002809302700106.","journal-title":"Ann Pharmacother"},{"key":"823_CR68","first-page":"1032","volume":"2","author":"NI Hamad","year":"2014","unstructured":"Hamad NI, Awad R, Salem AF, Arafat T. Pethidine level in Jordanian women and their newborns during labor after a single intravenous dose. Int J Clin Anesthesiol. 2014;2:1032.","journal-title":"Int J Clin Anesthesiol."},{"key":"823_CR69","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2125.1982.tb01352.x","volume":"13","author":"R Husemeyer","year":"1982","unstructured":"Husemeyer R, Cummings A, Rosankiewicz J, Davenport H. A study of pethidine kinetics and analgesia in women in labour following intravenous, intramuscular and epidural administration. Br J Clin Pharmacol. 1982;13:171\u20136. https:\/\/doi.org\/10.1111\/j.1365-2125.1982.tb01352.x.","journal-title":"Br J Clin Pharmacol"},{"key":"823_CR70","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/BF00542464","volume":"22","author":"L Holmberg","year":"1982","unstructured":"Holmberg L, Odar-Cederl\u00f6f I, Bor\u00e9us LO, Heyner L, Ehrnebo M. Comparative disposition of pethidine and norpethidine in old and young patients. Eur J Clin Pharmacol. 1982;22:175\u20139. https:\/\/doi.org\/10.1007\/BF00542464.","journal-title":"Eur J Clin Pharmacol"},{"key":"823_CR71","first-page":"193","volume":"63","author":"K Payne","year":"1983","unstructured":"Payne K. Epidural and intramuscular pethidine-a pharmacokinetic study. S Afr Med J. 1983;63:193\u20136.","journal-title":"S Afr Med J"},{"key":"823_CR72","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1399-6576.1983.tb01939.x","volume":"27","author":"LO Bor\u00e9us","year":"1983","unstructured":"Bor\u00e9us LO, Sk\u00f6ldefors E, Ehrnebo M. Appearance of pethidine and norpethidine in cerebrospinal fluid of man following intramuscular injection of pethidine. Acta Anaesthesiol Scand. 1983;27:222\u20135. https:\/\/doi.org\/10.1111\/j.1399-6576.1983.tb01939.x.","journal-title":"Acta Anaesthesiol Scand"},{"key":"823_CR73","first-page":"930","volume":"32","author":"J Ram\u00edrez","year":"2004","unstructured":"Ram\u00edrez J, Innocenti F, Schuetz EG, Flockhart DA, Relling MV, Santucci R, et al. CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes. Drug Metab Dispos. 2004;32:930\u20136.","journal-title":"Drug Metab Dispos"},{"key":"823_CR74","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00280-013-2275-x","volume":"72","author":"C Diestelhorst","year":"2013","unstructured":"Diestelhorst C, Boos J, McCune JS, Russell J, Kangarloo SB, Hempel G. Physiologically based pharmacokinetic modelling of Busulfan: a new approach to describe and predict the pharmacokinetics in adults. Cancer Chemother Pharmacol. 2013;72:991\u20131000. https:\/\/doi.org\/10.1007\/s00280-013-2275-x.","journal-title":"Cancer Chemother Pharmacol"},{"key":"823_CR75","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00280-019-03941-z","volume":"84","author":"JH Hughes","year":"2019","unstructured":"Hughes JH, Upton RN, Reuter SE, Rozewski DM, Phelps MA, Foster DJ. Development of a physiologically based pharmacokinetic model for intravenous lenalidomide in mice. Cancer Chemother Pharmacol. 2019;84:1073\u201387. https:\/\/doi.org\/10.1007\/s00280-019-03941-z.","journal-title":"Cancer Chemother Pharmacol"},{"key":"823_CR76","doi-asserted-by":"publisher","first-page":"704","DOI":"10.2174\/1871527320666210621102437","volume":"21","author":"MM Alsmadi","year":"2022","unstructured":"Alsmadi MM, Al Eitan LN, Idkaidek NM, Alzoubi KH. The development of a PBPK model for atomoxetine using levels in plasma, saliva and brain extracellular fluid in patients with normal and deteriorated kidney function. CNSNDDT. 2022;21:704\u201316. https:\/\/doi.org\/10.2174\/1871527320666210621102437.","journal-title":"CNSNDDT."},{"key":"823_CR77","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/bdd.2282","volume":"42","author":"MM Alsmadi","year":"2021","unstructured":"Alsmadi MM, Al-Daoud NM, Jaradat MM, Alzughoul SB, Abu Kwiak AD, Abu Laila SS, et al. Physiologically-based pharmacokinetic model for alectinib, ruxolitinib, and panobinostat in the presence of cancer, renal impairment, and hepatic impairment. Biopharm Drug Disposition. 2021;42:263\u201384. https:\/\/doi.org\/10.1002\/bdd.2282.","journal-title":"Biopharm Drug Disposition."},{"key":"823_CR78","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/jcph.1365","volume":"59","author":"YC Wong","year":"2019","unstructured":"Wong YC, Centanni M, de Lange EC. Physiologically based modeling approach to predict dopamine D2 receptor occupancy of antipsychotics in brain: translation from rat to human. J Clin Pharmacol. 2019;59:731\u201347. https:\/\/doi.org\/10.1002\/jcph.1365.","journal-title":"J Clin Pharmacol"},{"key":"823_CR79","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijpharm.2009.03.037","volume":"375","author":"HE Hassan","year":"2009","unstructured":"Hassan HE, Mercer SL, Cunningham CW, Coop A, Eddington ND. Evaluation of the P-glycoprotein (Abcb1) affinity status of a series of morphine analogs: comparative study with meperidine analogs to identify opioids with minimal P-glycoprotein interactions. Int J Pharm. 2009;375:48\u201354. https:\/\/doi.org\/10.1016\/j.ijpharm.2009.03.037.","journal-title":"Int J Pharm"},{"key":"823_CR80","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/jps.2600740517","volume":"74","author":"WG Kramer","year":"1985","unstructured":"Kramer WG, Gross DR, Medlock C. Contribution of the lung to total body clearance of meperidine in the dog. J Pharm Sci. 1985;74:569\u201371. https:\/\/doi.org\/10.1002\/jps.2600740517.","journal-title":"J Pharm Sci"},{"key":"823_CR81","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1002\/jps.20502","volume":"95","author":"T Rodgers","year":"2006","unstructured":"Rodgers T, Rowland M. Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. J Pharm Sci. 2006;95:1238\u201357. https:\/\/doi.org\/10.1002\/jps.20502.","journal-title":"J Pharm Sci"},{"key":"823_CR82","unstructured":"Alsmadi MM. Physiologically based pharmacokinetic (PBPK) model of ivermectin (IVM). 2014. https:\/\/www.proquest.com\/openview\/6b2ac6600b76fb8b784476e77e0a5a61\/1.pdf?pq-origsite=gscholar&cbl=18750. Accessed 26 Feb 2023."},{"key":"823_CR83","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00204-006-0114-0","volume":"80","author":"RE Sweeney","year":"2006","unstructured":"Sweeney RE, Langenberg JP, Maxwell DM. A physiologically based pharmacokinetic (PB\/PK) model for multiple exposure routes of soman in multiple species. Arch Toxicol. 2006;80:719\u201331. https:\/\/doi.org\/10.1007\/s00204-006-0114-0.","journal-title":"Arch Toxicol"},{"key":"823_CR84","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejpb.2010.06.003","volume":"76","author":"S Willmann","year":"2010","unstructured":"Willmann S, Thelen K, Becker C, Dressman JB, Lippert J. Mechanism-based prediction of particle size-dependent dissolution and absorption: cilostazol pharmacokinetics in dogs. Eur J Pharm Biopharm. 2010;76:83\u201394. https:\/\/doi.org\/10.1016\/j.ejpb.2010.06.003.","journal-title":"Eur J Pharm Biopharm"},{"key":"823_CR85","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/clpt.2008.1","volume":"84","author":"MF Hebert","year":"2008","unstructured":"Hebert MF, Easterling T, Kirby B, Carr D, Buchanan M, Rutherford T, et al. Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther. 2008;84:248\u201353. https:\/\/doi.org\/10.1038\/clpt.2008.1.","journal-title":"Clin Pharmacol Ther"},{"key":"823_CR86","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s40262-021-01046-6","volume":"60","author":"S Ganguly","year":"2021","unstructured":"Ganguly S, Edginton AN, Gerhart JG, Cohen-Wolkowiez M, Greenberg RG, Gonzalez D, et al. Physiologically based pharmacokinetic modeling of meropenem in preterm and term infants. Clin Pharmacokinet. 2021;60:1591\u2013604. https:\/\/doi.org\/10.1007\/s40262-021-01046-6.","journal-title":"Clin Pharmacokinet"},{"key":"823_CR87","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s40262-017-0576-7","volume":"57","author":"AR Maharaj","year":"2018","unstructured":"Maharaj AR, Gonzalez D, Cohen-Wolkowiez M, Hornik CP, Edginton AN. Improving pediatric protein binding estimates: an evaluation of \u03b11-acid glycoprotein maturation in healthy and infected subjects. Clin Pharmacokinet. 2018;57:577\u201389. https:\/\/doi.org\/10.1007\/s40262-017-0576-7.","journal-title":"Clin Pharmacokinet"},{"key":"823_CR88","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/QAI.0b013e31827fd47e","volume":"63","author":"KB Patterson","year":"2013","unstructured":"Patterson KB, Dumond JB, Prince HA, Jenkins AJ, Scarsi KK, Wang R, et al. Protein binding of lopinavir and ritonavir during four phases of pregnancy: implications for treatment guidelines. J Acquir Immune Defic Syndr. 2013;63:51. https:\/\/doi.org\/10.1097\/QAI.0b013e31827fd47e.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"823_CR89","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1365-2125.1984.tb02365.x","volume":"17","author":"C La Rosa","year":"1984","unstructured":"La Rosa C, Mather L, Morgan D. Pethidine binding in plasma: effects of methodological variables. Br J Clin Pharmacol. 1984;17:411\u20135. https:\/\/doi.org\/10.1111\/j.1365-2125.1984.tb02365.x.","journal-title":"Br J Clin Pharmacol"},{"key":"823_CR90","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/cpt1978233288","volume":"23","author":"D Morgan","year":"1978","unstructured":"Morgan D, Moore G, Thomas J, Triggs E. Disposition of meperidine in pregnancy. Clin Pharmacol Ther. 1978;23:288\u201395. https:\/\/doi.org\/10.1002\/cpt1978233288.","journal-title":"Clin Pharmacol Ther"},{"key":"823_CR91","volume-title":"Clinical pharmacokinetics and pharmacodynamics: concepts and applications","author":"M Rowland","year":"2005","unstructured":"Rowland M, Tozer TN. Clinical pharmacokinetics and pharmacodynamics: concepts and applications. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2005.","edition":"5"},{"key":"823_CR92","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1021\/acs.molpharmaceut.8b00941","volume":"16","author":"N Couto","year":"2019","unstructured":"Couto N, Al-Majdoub ZM, Achour B, Wright PC, Rostami-Hodjegan A, Barber J. Quantification of proteins involved in drug metabolism and disposition in the human liver using label-free global proteomics. Mol Pharm. 2019;16:632\u201347. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00941.","journal-title":"Mol Pharm"},{"key":"823_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i03","volume":"33","author":"K Soetaert","year":"2010","unstructured":"Soetaert K, Petzoldt T. Inverse modelling, sensitivity and monte Carlo analysis in R using package FME. J Stat Softw. 2010;33:1\u201328. https:\/\/doi.org\/10.18637\/jss.v033.i03.","journal-title":"J Stat Softw"},{"key":"823_CR94","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s40262-017-0525-5","volume":"56","author":"CP Hornik","year":"2017","unstructured":"Hornik CP, Wu H, Edginton AN, Watt K, Cohen-Wolkowiez M, Gonzalez D. Development of a pediatric physiologically-based pharmacokinetic model of clindamycin using opportunistic pharmacokinetic data. Clin Pharmacokinet. 2017;56:1343\u201353. https:\/\/doi.org\/10.1007\/s40262-017-0525-5.","journal-title":"Clin Pharmacokinet"},{"key":"823_CR95","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1002\/9780470921920.edm049","volume":"100","author":"R Do Jones","year":"2011","unstructured":"Do Jones R, Jones HM, Rowland M, Gibson CR, Yates JW, Chien JY, et al. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution. J Pharm Sci. 2011;100:4074\u201389. https:\/\/doi.org\/10.1002\/9780470921920.edm049.","journal-title":"J Pharm Sci"},{"key":"823_CR96","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/FTD.0000000000000056","volume":"36","author":"MR Sampson","year":"2014","unstructured":"Sampson MR, Frymoyer A, Rattray B, Cotten CM, Smith B, Capparelli E, et al. Predictive performance of a gentamicin population pharmacokinetic model in neonates receiving full-body hypothermia. Ther Drug Monit. 2014;36:584\u20139. https:\/\/doi.org\/10.1097\/FTD.0000000000000056.","journal-title":"Ther Drug Monit"},{"key":"823_CR97","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jpainsymman.2014.09.004","volume":"50","author":"T Heiskanen","year":"2015","unstructured":"Heiskanen T, Langel K, Gunnar T, Lillsunde P, Kalso EA. Opioid concentrations in oral fluid and plasma in cancer patients with pain. J Pain Symptom Manage. 2015;50:524\u201332. https:\/\/doi.org\/10.1016\/j.jpainsymman.2014.09.004.","journal-title":"J Pain Symptom Manage"},{"key":"823_CR98","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1016\/j.clinthera.2015.09.002","volume":"37","author":"SR Bista","year":"2015","unstructured":"Bista SR, Haywood A, Norris R, Good P, Tapuni A, Lobb M, et al. Saliva versus plasma for pharmacokinetic and pharmacodynamic studies of fentanyl in patients with cancer. Clin Ther. 2015;37:2468\u201375. https:\/\/doi.org\/10.1016\/j.clinthera.2015.09.002.","journal-title":"Clin Ther"},{"key":"823_CR99","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/jat\/bkaa069","volume":"44","author":"AM Gesseck","year":"2020","unstructured":"Gesseck AM, Poklis JL, Wolf CE, Xu J, Bashir A, Hendricks-Mu\u00f1oz KD, et al. A case study evaluating the efficacy of an ad hoc hospital collection device for fentanyl in infant oral fluid. J Anal Toxicol. 2020;44:741\u20136. https:\/\/doi.org\/10.1093\/jat\/bkaa069.","journal-title":"J Anal Toxicol"},{"key":"823_CR100","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/bdd.2206","volume":"40","author":"MM Alsmadi","year":"2019","unstructured":"Alsmadi MM, Alfarah MQ, Albderat J, Alsalaita G, AlMardini R, Hamadi S, et al. The development of a population physiologically based pharmacokinetic model for mycophenolic mofetil and mycophenolic acid in humans using data from plasma, saliva, and kidney tissue. Biopharm Drug Disposition. 2019;40:325\u201340. https:\/\/doi.org\/10.1002\/bdd.2206.","journal-title":"Biopharm Drug Disposition."},{"key":"823_CR101","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/j.1365-2044.1979.tb06247.x","volume":"34","author":"PC Wiener","year":"1979","unstructured":"Wiener PC, Hogg MI, Rosen M. Neonatal respiration, feeding and neurobehavioural state. Effects of intrapartum bupivacaine, pethidine and pethidine reversed by naloxone. Anaesthesia. 1979;34:996\u20131004. https:\/\/doi.org\/10.1111\/j.1365-2044.1979.tb06247.x.","journal-title":"Anaesthesia"},{"key":"823_CR102","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1651-2227.1995.tb13596.x","volume":"84","author":"E Nissen","year":"1995","unstructured":"Nissen E, Lilja G, Matthiesen A-S, Ransjo-Arvidsson A-B, Uvnas-Moberg K, Widstrom A-M. Effects of maternal pethidine on infants\u2019 developing breast feeding behaviour. Acta Paediatr. 1995;84:140\u20135. https:\/\/doi.org\/10.1111\/j.1651-2227.1995.tb13596.x.","journal-title":"Acta Paediatr"},{"key":"823_CR103","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1136\/emj.17.4.261","volume":"17","author":"A O'Connor","year":"2000","unstructured":"O\u2019Connor A, Schug SA, Cardwell H. A comparison of the efficacy and safety of morphine and pethidine as analgesia for suspected renal colic in the emergency setting. Emerg Med J. 2000;17:261\u20134. https:\/\/doi.org\/10.1136\/emj.17.4.261.","journal-title":"Emerg Med J"},{"key":"823_CR104","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10928-020-09706-z","volume":"47","author":"A Dallmann","year":"2020","unstructured":"Dallmann A, Himstedt A, Solodenko J, Ince I, Hempel G, Eissing T. Integration of physiological changes during the postpartum period into a PBPK framework and prediction of amoxicillin disposition before and shortly after delivery. J Pharmacokinet Pharmacodyn. 2020;47:341\u201359. https:\/\/doi.org\/10.1007\/s10928-020-09706-z.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"823_CR105","doi-asserted-by":"publisher","first-page":"520","DOI":"10.2174\/138920009788897993","volume":"10","author":"P Pavek","year":"2009","unstructured":"Pavek P, Ceckova M, Staud F. Variation of drug kinetics in pregnancy. Curr Drug Metab. 2009;10:520\u20139. https:\/\/doi.org\/10.2174\/138920009788897993.","journal-title":"Curr Drug Metab"},{"key":"823_CR106","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2165\/00003088-198207050-00003","volume":"7","author":"D Edwards","year":"1982","unstructured":"Edwards D, Svensson CK, Visco JP, Lalka D. Clinical Pharmacokinetics of Pethidine: 1982. Clin Pharmacokinet. 1982;7:421\u201333. https:\/\/doi.org\/10.2165\/00003088-198207050-00003.","journal-title":"Clin Pharmacokinet"},{"key":"823_CR107","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-2125.1981.tb01097.x","volume":"11","author":"K Austin","year":"1981","unstructured":"Austin K, Stapleton J, Mather L. Pethidine clearance during continuous intravenous infusions in postoperative patients. Br J Clin Pharmacol. 1981;11:25\u201330. https:\/\/doi.org\/10.1111\/j.1365-2125.1981.tb01097.x.","journal-title":"Br J Clin Pharmacol"},{"key":"823_CR108","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1128\/AAC.00133-06","volume":"52","author":"S Kiem","year":"2008","unstructured":"Kiem S, Schentag JJ. Interpretation of antibiotic concentration ratios measured in epithelial lining fluid. Antimicrob Agents Chemother. 2008;52:24\u201336. https:\/\/doi.org\/10.1128\/AAC.00133-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"823_CR109","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.24.20078741","author":"G Aljayyoussi","year":"2020","unstructured":"Aljayyoussi G, Rajoli R, Pertinez H, Pennington S, Hong WD, O\u2019Neill P, et al. Modelling of systemic versus pulmonary chloroquine exposure in man for COVID-19 dose selection. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.04.24.20078741.","journal-title":"medRxiv."},{"key":"823_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2021.462769","volume":"1664","author":"M Sch\u00fcller","year":"2022","unstructured":"Sch\u00fcller M, Tran KTT, \u00d8iestad EL, Pedersen-Bjergaard S. Membrane-based liquid-phase microextraction of basic pharmaceuticals\u2014a study on the optimal extraction window. J Chromatogr A. 2022;1664: 462769. https:\/\/doi.org\/10.1016\/j.chroma.2021.462769.","journal-title":"J Chromatogr A"},{"key":"823_CR111","unstructured":"DrugBank. Meperidine- Compound summary. 1992. https:\/\/go.drugbank.com\/drugs\/DB00454. Accessed 26 May 2022."},{"key":"823_CR112","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1124\/dmd.108.021311","volume":"36","author":"ZE Barter","year":"2008","unstructured":"Barter ZE, Chowdry JE, Harlow JR, Snawder JE, Lipscomb JC, Rostami-Hodjegan A. Covariation of human microsomal protein per gram of liver with age: absence of influence of operator and sample storage may justify interlaboratory data pooling. Drug Metab Dispos. 2008;36:2405\u20139. https:\/\/doi.org\/10.1124\/dmd.108.021311.","journal-title":"Drug Metab Dispos"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-023-00823-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-023-00823-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-023-00823-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T10:24:22Z","timestamp":1683800662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-023-00823-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":112,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["823"],"URL":"https:\/\/doi.org\/10.1007\/s13318-023-00823-x","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,5]]},"assertion":[{"value":"27 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received no funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Mo\u2019tasem M. Alsmadi and Nasir Idkaidek declare that they have no conflict of interest","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All of the used data in this work were included in the article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The PK-Sim files used in this work can be provided upon request via email.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"MMA had substantial contributions to the conception and design of the work; the acquisition, analysis, and interpretation of data, and the drafting of the work. MMA and NI were involved in revising the work critically for important intellectual content. All authors provided final approval of the version to be published and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}